Organigram Targets U.S. Expansion Amidst Market Challenges and THC Inflation

10w
2m read
Summary

As the prevalence of THC inflation decreases through increased enforcement, companies like Organigram, already producing quality, high-THC products, will continue to rise. Canadian cannabis producer Organigram Holdings is exploring international investment opportunities, especially in the U.S. market, as stated by CEO Beena Goldenberg. The unique challenge for international expansion lies in the federal illegality of cannabis in the U.S., which requires companies to structure their acquisitions compliantly. By focusing on high-THC flower sales, research and development, and efficient production methods, Organigram aims to maintain its position as a leader within the industry while continuing to pursue global expansion. Adult-use cannabis revenue slightly decreased compared to the same quarter a year ago.Leveraging High-THC Flower Sales for GrowthOrganigram’s focus on high-THC flower products has given them an edge in capturing a significant portion of the Canadian market.

Article Preview

Canadian cannabis producer Organigram Holdings is exploring international investment opportunities, especially in the U.S. market, as stated by CEO Beena Goldenberg. While the company’s revenue was CA$36.5 million during the October-December quarter, it fell short of analysts’ expectations of CA$37.8 million. The unique challenge for international expansion lies in the federal illegality of cannabis in the U.S., which requires companies to structure their acquisitions compliantly. Organigram will observe how other companies achieve this and learn from them.

The cannabis industry has seen “THC inflation,”...

Read the full article @ Marijuana Index